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Background: D-2,3-butanediol has many industrial applications such as chiral reagents, solvents, anti-freeze agents,
and low freezing point fuels. Traditional D-2,3-butanediol producing microorganisms, such as Klebsiella pneumonia
and K. xoytoca, are pathogenic and not capable of producing D-2,3-butanediol at high optical purity. Bacillus
licheniformis is a potential 2,3-butanediol producer but the wild type strain (WX-02) produces a mix of D- and
meso-type isomers. BudC in B. licheniformis is annotated as 2,3-butanediol dehydrogenase or acetoin reductase, but
no pervious experiment was performed to verify this hypothesis.
Results: We developed a genetically modified strain of B. licheniformis (WX-02 ΔbudC) as a D-2,3-butanediol
producer with high optimal purity. A marker-less gene deletion protocol based on a temperature sensitive
knock-out plasmid T2-Ori was used to knock out the budC gene in B. licheniformis WX-02. The budC knock-out strain
successfully abolished meso-2,3-butanediol production with enhanced D-2,3-butanediol production. No meso-BDH
activity was detectable in cells of this strain. On the other hand, the complementary strain restored the characteristics
of wild strain, and produced meso-2,3-butanediol and possessed meso-BDH activity. All of these data suggested that
budC encoded the major meso-BDH catalyzing the reversible reaction from acetoin to meso-2,3-butanediol in B.
licheniformis. The budC knock-out strain produced D-2,3-butanediol isomer only with a high yield of 30.76 g/L and a
productivity of 1.28 g/L-h.
Conclusions: We confirmed the hypothesis that budC gene is responsible to reversibly transfer acetoin to
meso-2,3-butanediol in B. licheniformis. A mutant strain of B. licheniformis with depleted budC gene was successfully
developed and produced high level of the D-2,3-butanediol with high optimal purity.
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D-2,3-butanediol as one of the promising bulk chemicals
has extensive applications in cosmetics, foods, transport
fuels, medicines, and polymers industries [1]. In general,
2,3-butanediol exists in three stereoisomeric forms: D-2,
3-butanediol, L-2,3-butanediol and meso-2,3-butanediol
[2]. All these isomers are valuable chemicals that provide
chiral groups in drugs [3]. D-2,3-butanediol is also used
as an antifreeze agent because of its low freezing point* Correspondence: mel212@126.com
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stated.(−60°C) [1]. The production of 2,3-butanediol with high
optical purities is therefore highly desirable [4,5].
Although many microorganisms are capable of synthe-
sizing 2,3-butanediol, the production processes are hin-
dered by various limitations. For example, traditional
2,3-butanediol producing microorganisms, such as Klebsi-
ella pneumonia and K. xoytoca, are pathogenic [2,6] and
produce a mixture of meso- and L-isomers with low yield
and productivity [2,7]. Non-pathogenic species such as
Paenibacillus polymyxa can produce D-2,3-butanediol
with a high (up to 98%) enantioselective purity; however,
the cell density and the overall D-2,3-butanediol product-
ivity is low as the cells need to be grown in micro-aerobicThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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yeast extract and tryptone, which increases the medium
cost and the production recovery cost [8]. Bacillus licheni-
formis, which is a generally-regarded-as-safe (GRAS) or-
ganism, is also capable of producing 2,3-butanediol at the
industrial level [6,9,10]; however, the wild-type B. licheni-
formis produces a mix of D- and meso-2,3-butanediol
isomers [6].
The metabolic pathway from pyruvate to 2,3-butanediol
has been well studied in B. subtilis. As shown in Figure 1,
pyruvate is converted to α-acetolactate, and consequently
to acetoin. At high dissolved-oxygen and glucose-rich
conditions, acetoin can be further converted into 2,3-buta-
nediol by the enzyme called acetoin reductase (AR). The
same protein can catalyze the reverse reaction from 2,
3-butanediol to acetoin as well, when dissolved oxygen is
limited and glucose is depleted. In this case, however, the
enzyme is called 2,3-butanediol dehydrogenase (BDH)
[1,11]. The meso-AR/BDH is encoded by the bdhA gene
in B. subtilis, therefore, modification of the bdhA gene
may be an efficient way to increase the optical purity of
D-2,3-butanediol while avoiding the formation of meso-
2,3-butanediol by B. subtilis [1].
Research has been attempted to produce 2,3-butane-
diol with high optical purity using genetically engineered
microorganisms. For example, Nielsen et al. [12] intro-
duced the acetoin and meso-2,3-butanediol biosynthesis
pathway in Escherichium coli by co-expression of 2,3-













Figure 1 Metabolic pathways to acetoin and 2,3-butanediol optical is
BDH, 2,3-butanediol dehydrogenase (reverse reaction); NADH, nicotinamideresulting in 1.12 g/L meso-2,3-butanediol [12]. Li et al.
[13] also transferred the gene encoding 2,3-butanediol
dehydrogenase from Enterobacter cloacae to E. coli for
expressing L-2,3-butanediol from diacetyl with concen-
trations of 16.1 g/L and 26.8 g/L of L-2,3-butanediol
produced in batch and fed-batch fermentation, respect-
ively. Although production of high optical purity of 2,
3-butanediol isomers has been achieved in engineered
E. coli, the product yield was usually very low, mainly
due to the weak overflow of the metabolic pathway in
E. coli cells.
Compared to E. coli, Bacillus species such as B. liche-
niformis, B. subtilis, and B. amyloliquefaciens have a
strong overflow metabolic pathway from glucose. There-
fore, modification of the metabolic pathway of Bacillus
species provides a promising way for producing pure
2,3-butanediol isomer with high product titer. In our
previous work, we have isolated a strain of B. lichenifor-
mis (termed WX-02), which showed a rapid growth and
capability of producing γ-poly-glutamic acid (γ-PGA) ac-
companied with 2,3-butanediol and acetoin [14]. Similar
to B. subtilis and other B. licheniformis strains, however,
B. licheniformis WX-02 produces a mixture of D-2,3-buta-
nediol and meso-2,3-butanediol [11,14,15]. Furthermore,
the genome of B. licheniformis WX-02 was sequenced and
the data submitted [GenBank: AHIF01000000], but a gene
similar to the bdhA gene in B. subtilis was not found in B.
licheniformis WX-02. The gene budC (gene ID: 3100198)




omers in B. licheniformis. AR, acetoin reductase (forward reaction);
adenine dinucleotide.
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ATCC 14580 (DSM 13) [16], although it has little simi-
larity (1.67% identity aligned by UniProt (http://www.
uniprot.org/?tab=align)) to bdhA in B. subtilis. The cell
extract of B. licheniformis also shows AR (BDH) activity,
with acetoin, D-2,3-butanediol and meso-2,3-butanediol
also being identified. All these results indicate the exist-
ence of the gene encoding AR (BDH) in B. licheniformis
[17,18]. Recent research by Li et al. [10] also shows that
the recombinant E. coli containing the BDH and glycerol
dehydrogenase (GDH) encoding gene from B. lichenifor-
mis exhibited meso-BDH and D-BDH activity in vitro [10].
The objective of this work was to investigate the specific
function of budC in the metabolism of acetoin and 2,3-
butanediol in B. licheniformis WX-02, followed with de-
veloping a strategy of knocking out the budC gene so
the production of the sole D-2,3-butanediol isomer can
be achieved.
Results
Establishment of the budC gene knock-out strain and
complementary strain
Figure 2 shows the plasmids for deletion of the budC gene
and for construction of the complementary strain. These
two plasmids were used for transformation of B. licheni-
formis WX-02 for making the budC deletion mutant and
its complementary strain, respectively. The positive strains
were then verified by PCR and sequencing.
The PCR results for verification of budC knock-out are
shown in Figure 3A. The PCR product amplified from the
genomic DNA of budC knock-out strain was about
1,500 bp; while a DNA fragment of about 2200 bp con-
taining the budC gene and its up- and down- stream se-
quences was amplified from the genomic DNA of wild
strain WX-02 by using primers of ΔbudC-F and ΔbudC-RA                          B
Figure 2 Construction of recombinant vectors. (A) Recombinant vector
sensitive replicon from B. subtilis (194-Ori), Kanamycin-resistant gene (Kan),
(B) Recombinant vector of pHYbudC for expression of budC in B. licheniform
promoter, the budC gene and the α-amylase gene (amyL) transcription termas negative control. The PCR product from budC knock-
out strain was purified and sequenced, and no other
mutation than the budC deletion was found (data not
shown), suggesting the successful construction of the
budC deficient strain (WX-02 ΔbudC). The comple-
mentary strain of WX-02 ΔbudC (terms as WX-02
ΔbudC/pHYbudC), was also verified by PCR. As shown
in Figure 3B, a DNA fragment of about 1500 bp was
amplified from the recombinant plasmid of transfor-
mant with a matched size to the fusion fragment of
P43-budC-TamyL, and then further verified by DNA se-
quencing (data not shown).
Effect of budC knock-out on meso-AR/meso and BDH
activities
As described in Figure 1, the enzyme catalyzing the con-
version between acetoin and 2,3-butanediol exhibits two
activities depending on the culture conditions: AR activ-
ity for reduction of acetoin to 2,3-butanediol and BDH
activity for dehydrogenation of 2,3-butanediol to acetoin.
To investigate the effect of budC knock-out on AR and
BDH activities, strains WX-02, WX-02 ΔbudC and WX-
02 ΔbudC/pHYbudC were cultured for 12, 24 and 36 h;
the specific activities of meso-BDH, AR, and D-BDH in
the cell extracts were analyzed. As shown in Figure 4A,
no meso-BDH activity was detected in the cell extracts
of WX-02 ΔbudC throughout the culture; whereas both
WX-02 and WX-02 ΔbudC/pHYbudC exhibited a high
meso-BDH activity. As for the AR activity, WX-02 ΔbudC
exhibited a very weak AR activity as compared to the
other two strains (WX-02 and WX-02 ΔbudC/pHYbudC)
(Figure 4B). Figure 4C shows that D-BDH activity of WX-
02 ΔbudC was comparable to that of WX-02 and WX-02
ΔbudC/pHYbudC (Figure 4C). Collectively, the above re-
sults indicate that the deletion of the budC gene had aI
T2ΔbudC for budC knock-out. The vector contained a temperature-
and the homologous arm A and B for homologous recombination.
is. The vector contained budC expression cassette including P43





Figure 3 PCR verification of recombinant strains. (A) PCR verification of budC knock-out strain. M, DL5000 marker (5,000, 3,000, 2,000, 1,500,
1,000, 750, 500, 250 and 100 bp, up to bottom); lane 1, negative control (PCR product from the genomic DNA of B. licheniformis WX-02); lanes 2
and 3, fragment amplified from the genomic DNA of B. licheniformis WX-02ΔbudC. (B) PCR verification of complementary strain of B. licheniformis
WX-02 ΔbudC/pHYbudC. M, DL5000 marker; lane 1, PCR product of fusion fragment of P43-budC-TamyL from recombinant strain B. licheniformis
WX-02 ΔbudC/pHYbudC.
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ity, indicating that the budC gene encodes meso-BDH but
not D-BDH. It should also be noted that WX-02 ΔbudC/
pHYbudC restored both meso-AR and meso-BDH activ-
ities compared to the budC gene knock-out strain; these
two enzyme activities in WX-02 ΔbudC/pHYbudC were
higher than those in WX-02 (Figure 4A and B). The rea-
son may be due to the multicopy of the budC gene con-
trolled by a strong promoter of P43 in WX-02 ΔbudC/
pHYbudC strain as compared to the wild-type strain [19].
Effects of budC deletion on 2,3-butanediol configurations
Among the three stereoisomers of 2,3-butanediol, D- and
L-types are racemic and can only be separated in a chiral
column; they can be easily separated from the meso-type
by ordinary non-chiral gas chromatograph (GC) capillary
columns [4]. In this study, therefore, D-2,3-butanediol and
meso-2,3-butanediol produced by B. licheniformis [2,17]
were separated by ordinary non-chiral GC.
Strains WX-02, WX-02 ΔbudC and WX-02 ΔbudC/
pHYbudC were respectively cultured for 24 h and then
2,3-butanediol in broth was determined. As shown in
Figure 5, D-2,3-butanediol and meso-2,3-butanediol were
well-separated. WX-02 ΔbudC produced D-2,3-butane-
diol but no meso-2,3-butanediol, whereas WX-02 and
WX-02 ΔbudC/pHYbudC generated both D-2,3-butanediol
and meso-2,3-butanediol (Figure 5). The result clearly
shows that the synthesis of meso-2,3-butanediol in budC
knocked-out strain (WX-02 ΔbudC) was successfully de-
leted, whereas the complementation of the budC knock-out
strain (WX-02 ΔbudC/pHYbudC) restored the capability of
meso-2,3-butanediol synthesis. The result confirmed thatthe budC gene was responsible for meso-2,3-butanediol
production in B. licheniformis. Unexpectedly, the trans-
formed strain (WX-02 ΔbudC/pHYbudC) had a higher
meso-BDH activity, but this strain did not produce more
meso-2,3-butanediol than the wild-type (WX-02). We be-
lieve that the synthesis of meso-2,3-butanediol in this trans-
formant may be controlled by other rate-limiting factors.
For example, the conversion from acetoin to meso-2,3-
butanediol also needs nicotinamide adenine dinucleotide
(NADH) as the electro-donor [6,18]; this NADH in the
transformant may be the controlling factor, although the
activity of meso-BDH is higher in the strain.
Production of 2,3-butanediol and acetoin by budC
knock-out strain and wild-type strain
The production profile of 2,3-butanediol and acetoin by
the wild strain and budC knock-out strain are presented in
Figure 6. As shown in Figure 6A, wild-strain WX-02 pro-
duced both D- and meso-types of 2,3-butanediol through-
out the culture. The concentration of these two isomers
increased in the first 24 h; beyond this culture time, D-2,3-
butanediol concentration decreased whereas meso-2,3-
butanediol leveled off in the remainder of the culture
period. For the culture of WX-02 ΔbudC strain, however,
only the D-type of 2,3-butanediol was produced through-
out all the culture. The D-2,3-butanediol concentration in-
creased for the first 24 h, and decreased afterwards. Only a
trace amount of meso-2,3-butanediol was detected at the
end of culture (48 h) of WX-02 ΔbudC. Throughout all the
culture period, the concentration of D-2,3-butanediol in
the WX-02 ΔbudC culture was approximately the summa-
tion of the D- and meso-2,3-butanediol isomers in the
Figure 4 Activity of 2,3-butanediol dehydrogenas (BDH) and acetoin reductase (AR) in different B. licheniformis. (A) meso-BDH activity;
(B) AR activity; (C) D-BDH activity. The data are expressed as mean ± standard error of three replicates.
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ally formed in the wild-type cells switched to additional
D-2,3-butanediol in the WX-02 ΔbudC mutant. The above
production profiles for D- and meso-type of 2,3-butanediol
were also reported in the culture of B. subtilis and Serratia
marcescens [9,20].
As for the production of acetoin and total 2,3-butanediol,
Figure 6B shows that for both the wild-type and budC gene
knock-out strain, total 2,3-butanediol production increasedrapidly in the first 24 h and gradually decreased afterwards;
concurrently, the acetoin production of the two strains was
low in the first 24 h, but increased rapidly from 24 to 36 h.
The loss of the budC gene in the WX-02 ΔbudC strain
resulted in more acetoin accumulation than wild strain
after 36 h.
Figure 6C shows pH change, glucose utilization, and
biomass density of the two strain cultures. The pH values
were low in the first 24 h, indicating the synthesis of
D-2,3-butanediol
meso-2,3-butanediol 
Figure 5 Chromatograph profile of 2,3-butanediol produced from different B. licheniformis strain cultures. (A) WX-02; (B) WX-02 ΔbudC;
(C) WX-02 ΔbudC/pHYbudC.
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synthesis of 2,3-butanediol (Figure 6B). In the later stage
of culture, the slight increase in pH favored the conversion
of D-2,3-butanediol to acetoin, which is evidenced by
the increased concentration of acetoin in the medium
(Figure 6B). The similar trend between pH and acetoin/
2,3-butanediol conversion was also found in B. subtilis[21]. Figure 6B also shows that glucose for the two cul-
tures had a similar trend; the glucose was rapidly con-
sumed within the first 24 h, which corresponds to a
rapid cell growth in the two cultures. After 24 h the glu-
cose in the medium was almost depleted; as a result the
cells of both the wild-type strain and budC-gene knock-
out mutant ceased growth due to the glucose (Figure 6C).
AC



















































Figure 6 Comparison of metabolites production, cell growth, and glucose consumption profile by wild-type (WX-02) and budC knock-out
(WX-02 ΔbudC) B. licheniformis strains. (A) D- and meso-2,3-butanediol production. (B) Total 2,3-butanediol and acetoin production. (C) Cell density,
medium pH, and residual glucose concentration. Data are expressed as mean ± standard errors of three replicates. BDL, butanediol.
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than the mutant; the reason was probably due to the con-
sumption of acetoin by the wild-type strain for supporting
the cell growth. Indeed, it has been reported that acetoin
can be a good carbon source for the culture of B. licheni-
formis once the major carbon source, glucose, is depleted
[20,22]. This may also explain why the acetoin concentra-
tion in the mutant culture was much higher than that in
the wild-type strain (Figure 6B).
Discussion
As a valuable compound, D-2,3-butanediol has been
widely used as a major composition in solvents, anti-
freeze agents, synthetic rubber, and plastics [2]. It can
also be used as a potential fuel with a low freezing point
and its heating value is comparable to that of ethanol
and methanol [6]. Various efforts have been attempted
for producing optical purity of D-2,3-butanediol by gen-
etically modified microorganisms; however, the yield of
D-2,3-butanediol has still been very low. For example,
recombinant E. coli expressing the enzyme BDH was
found to produce 6.1 g/L of D-2,3-butanediol [21], and
B. licheniformis with a deleted lactate dehydrogenase
gene (ldh) to produce 13.77 g/L of D-2,3-butanediol [6].
Heterologous expression of acetoin reductase of Clos-
tridium beijerinckii in C. acetobutylicum has resulted in
a range of 1.8 to 1.98 g/L D-2,3-butanediol [7].
The strain B. licheniformis, WX-02, used in this study
was previously isolated for the production of γ-PGA
with 2,3-butanediol and acetoin being the co-products.
This strain can grow in a simple medium containing glu-
cose, glutamic acid, and mineral salts [14]. As the strain
WX-02 produces mixed stereoisomers of 2,3-butanediol,
modification of its metabolic pathway for sole production
of pure isomer of D-2,3-butanediol is desirable. To date,
there have been several challenges to making a recombin-
ant strain of B. licheniformis, including low transformation
efficiency and a lack of information about the meso-BDH
encoding gene. For example, Wang et al. [6] successfully
deleted the ldh gene from genomic DNA in B. licheniformis
by transforming protoplasts of the cells with a recombinant
knock-out plasmid; however, the designed protoplast sys-
tem was very complicated and the transformation efficiency
was low [6]. In this paper, we successfully transformed B.
licheniformis WX-02 with a recombinant knock-out plas-
mid with high efficiency. It demonstrates that T2-ori-based
knock-out plasmid and the electro-transformation ap-
proach can be used for the metabolic modification of
the B. licheniformis WX-02 strain for producing pure D-
2,3-butanediol with high titer.
Previous reports showed that the bdhA gene encoding
BDH is responsible for catalyzing acetoin to 2,3-butane-
diol in B. subtilis, and the insertion inactivation of bdhA
completely blocks 2,3-butanediol synthesis [11]. For B.licheniformis, however, no bdhA gene was found in the
genome. In the attempt for identifying the gene respon-
sible for catalyzing acetoin to 2,3-butanediol in B. liche-
niformis, Wang et al. [6] reported the depletion of the
ldh gene for the production of high optical purity of D-
2,3-butanediol in B. licheniformis with 13.77 g/L D-2,3-
butanediol being produced in optimized conditions [6].
However, our previous study in knocking out the ldh
gene in B. licheniformis WX-02 to block lactate accumula-
tion resulted in reduced acetoin and 2,3-butanediol pro-
duction (unpublished data). The recent report showed
that the budC gene might be the gene encoding meso-
BDH in B. licheniformis according to the detectable en-
zyme activity of the recombinant protein of bdh (same as
budC) gene by E. coli [10]. Therefore, we hypothesized
that the budC gene is responsible for catalyzing acetoin to
meso-2,3-butanediol in B. licheniformis.
Our previous research shows that the budC gene in B.
licheniformis might be annotated as BDH for this species
[16]. In this work, we confirmed the budC in B. licheni-
formis as the gene encoding meso-BDH for the reversible
reaction from acetoin to meso-2,3-butanediol [18], based
on the fact that the deletion of budC gene in B. licheni-
formis WX-02 completely blocked meso-2,3-butanediol
production with significant enhanced production of D-
2,3-butanediol (Figure 6A). However, the BudC protein
sequence [NCBI: YP_006713433.1], aligned by blastP in
the NCBI non-redundant protein database, showed that
only one protein from B. sonorensis annotated as 2,3-BDH,
AR or diacetyl reductase was similar (E-value <8e-112) to
BudC protein. Moreover, the BudC protein sequence has a
very low identity with the BDH found in other Bacillus
species. For example, it has only 11.67%, 9.98% and 11.58%
similarity to the BDHs from B. subtilis 168 (NP_388505.1),
B. cereus YUF-4 (BAB60856.1) and B. amyloliquefaciens
DSM 7 (YP_003919213.1), respectively. All these results in-
dicate that unique BDH-encoding gene in B. licheniformis
is different from other Bacillus genus.
Although the deletion of budC gene caused a slight
decrease (about 5 to 10%) in cell growth (Figure 6C), it
significantly enhanced the D-2,3-butanediol production
(Figure 6C) (30.76 g/L) compared to both the wild strain in
this work and the genetically modified strain with the dele-
tion of the ldh gene (13.77 g/L) [6]. Finally, it should be
noted that even when budC was deleted from the B. liche-
niformis WX-02 genome, there was still a small amount of
meso-2,3-butanediol found at the end of fermentation
period (Figure 6A). This may be due to the existence of
other genes encoding minor meso-BDHs, or acetylacetoin
reductase catalyzing acetoin to meso-2,3-butanediol [18].
Indeed, low concentration of glucose and high concentra-
tion of acetoin, as found in this work (Figure 6A and C),
can induce acetylacetoin synthase to transform acetoin to
meso-2,3-butanediol through the 2,3-butanediol cycle [18].
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In summary, this report revealed the specific function
of budC for the transformation between acetoin and 2,
3-butanediol in B. licheniformis. The D-2,3-butanediol
production level obtained in this work was the highest
among the reported Bacillus genus. The study provides a
deep understanding of acetoin and 2,3-butanediol metab-
olism in B. licheniformis, and a possible way for enhancing
the production of pure D-2,3-butanediol isomer through
genetic modification.
Materials and methods
Cell strain, plasmids, primers and growth media
Experiments were performed with the strains and plas-
mids listed in Table 1. The oligonucleotide primers listed
in Table 2 were designed on the basis of B. licheniformis
WX-02 genome sequence [GenBank: AHIF00000000]
[16]. Luria-Bertani (LB) medium was prepared for
culture of E. coli DH5α and also B. licheniformis [23].
Medium used for culturing B. licheniformis was a slight
modification of that described in a previous report [24],
consisting of (per liter) 120 g glucose, 33 g corn steep li-
quor, 9.00 g (NH4)2SO4, 1.00 g K2HPO4, 1.50 g MgSO4,
0.50 g NaCl, 0.12 g ZnCl2, 1 mg FeCl3, and 1 mg
MnSO4. The medium was adjusted to 7.0 before auto-
claving at 121°C for 15 minutes.
Chemicals and materials for cloning
Acetoin (98%) and 2,3-butanediol (98%) were purchased
from Shanghai Jingchun Reagent (China). D-2,3-butane-
diol (>96%) was purchased from Tokyo Chemical Industry
(Tokyo, Japan), meso-2,3-butanediol (99%) was purchased
from Sigma-Aldrich (Sigma, St. Louis, MO, USA). All
other chemicals were of analytical grade supplied byTable 1 Bacterial strains and plasmids used in this study
Strains and plasmids Characteristicsa
E. coli strains
DH5α F– Φ80d/lacZΔM15, Δ(lacZYA-argF) U16
phoA, supE44, λ–, thi-1, gyrA96, relA1
B. licheniformis strains
WX-02 CCTCC M208065, wild type
WX-02 ΔbudC budC knock-out mutant of WX-02
WX-02 ΔbudC/pHYbudC plasmid-based budC complementation
of pHYbudC, Tcr
Plasmids
T2(2)-ori E. coli-B. licheniformis shuttle vector, orip
T2ΔbudC T2(2)-ori derivative containing homolog
pHY300PLK E. coli-B. licheniformis shuttle vector, Apr
pHYbudC pHY300PLK derivative containing budC,
terminator), Apr(E. coli), Tcr(E. coli and B.
aTcr, tetracycline resistance; Apr, ampicillin resistance; orits, temperature-sensitive Ba
Type Culture Collection.Sinopharm Chemical Reagent (Shanghai, China). T4 DNA
ligase and DNA marker were purchased from Takara
Bio (Dalian, China). TransStart FastPfu DNA Polymerase
was purchased from TransGen Biotech (Beijing, China).
Plasmid Miniprep Kit was obtained from Zoman Biotech
(Beijing, China). Nucleotide sequences were determined
by Beijing Genomics institution (Beijing, China).
Construction of plasmids
B. licheniformis WX-02 or B. subtilis 168 was cultured in
LB medium overnight, and then collected for extraction of
genomic DNA based on the method described previously
[25]. The extracted genomic DNA was stored at −20°C
prior to use. The gene budC was deleted by the double-
crossover homologous recombination method with the
primers listed in Table 2. First, two homologous arms
(homologous to the 5′ and 3′ coding regions of the budC
gene) of approximately 500 bp were amplified by PCR
from the genomic DNA of B. licheniformis WX-02 by
primers of ΔbudC-A-F and ΔbudC-A-R, ΔbudC-B-F and
ΔbudC-B-R, respectively. These two homologous arms
were ligated by splicing with overlapping extension PCR
(SOE-PCR) with primers of ΔbudC-A-F and ΔbudC-B-R
[6]. The DNA fragment was subcloned in vector T2(2)-ori
joined by BamH I and Xba I restriction sites. T2(2)-ori
was a previously constructed shuttle plasmid for con-
struction of knock-out vector for B. licheniformis, with a
temperature-sensitive replicon from B. subtilis to pro-
mote single crossover in bacterial cells [26]. The result-
ing plasmid was further verified by sequencing. A
recombinant vector for budC knock-out was designated
as T2ΔbudC (Figure 2A).
The fusion of the P43 promoter of B. subtilis 168,
budC gene of WX-02, and terminator of amyL gene ofSource or reference





strain of WX-02 ΔbudC by introduction This study
UC/orits, temperature-sensitive, Kan
r Laboratory stock
ous arms for budC knock-out This study
(E. coli), Tcr(E. coli and B. licheniformis) TaKaRa
P43 promoter and TamyL (amyL
licheniformis)
This study
cillus origin of replication; Kanr, Kanamycin resistance; CCTCC, China Center for
Table 2 Primers used in this study













ΔbudC A signal crossover-F CTTCACATGGACGATCCTAAT
ΔbudC A single crossover-R TGTTCCTCCGTAAACCGCTAAG
ΔbudC B single crossover-F CAACCACCCCTATTGAAAGCAT
ΔbudC B single crossover-R GATACCTGTCCGCCTTTCTCC
aRestriction sites highlighted in bold. Italics stands for the overlap region for splicing by overlapping extension PCR (SOE-PCR).
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primers of P43-budC-TamyL-1 to 6 (Table 2) and tem-
plates of genomic DNA from B. licheniformis WX-02 or
B. subtilis 168. Then the DNA fragment amplified by
SOE-PCR was cloned into the plasmid of pHY300PLK
joined by the BamH I and EcoR I restriction sites. The
resulting plasmid was verified by sequencing. A recom-
binant vector for expression of budC in B. licheniformis
WX-02 was designated as pHYbudC (Figure 2B).
Construction of the budC knock-out strain of WX-02
Competent cells of E. coli DH5α and B. licheniformis
WX-02 were prepared for transformation of constructed
plasmids as described previously [23,27]. E. coli DH5α
was transferred with T2ΔbudC plasmid and cultured in
LB medium with kanamycin (20 μg/mL). The plasmid
T2ΔbudC isolated from the recombinant E. coli DH5α
was used for transforming into B. licheniformis WX-02.
B. licheniformis WX-02 was electrotransformed with the
recombinant T2ΔbudC plasmid according to the method
described previously [27]; the transformants were selected
by kanamycin resistance (20 μg/mL) followed with verifi-
cation by PCR using the primers ΔbudC-A-F and ΔbudC-
B-R (Table 2). The selected positive transformant was
cultured in LB medium containing kanamycin (20 μg/mL)
at 45°C for 8 h, and the temperature-sensitive replicon of
the T2ΔbudC plasmid did not work at this temperature.
Therefore, the high growth temperature promoted the
first crossover in the cells. The mutants with kanamycin
resistance were selected, and further verified by PCR with
primers of ΔbudC A single crossover-F and ΔbudC Asingle crossover-R for crossover upstream, or ΔbudC B
single crossover-F and ΔbudC B single crossover-R for
crossover downstream. Then the selected colonies with
single crossover were picked up and cultured in LB
medium at 37°C for 8 hours, this process was repeated
six times. After serial transfer without antibiotics, cells
were plated on LB agar plates, and then replicated in
kanamycin plates for selection of kanamycin-sensitive
colonies. The budC knock-out strains that had looped
out the kanamycin-resistant gene by the second crossover
were selected. The mutant WX-02 ΔbudC was confirmed
by PCR with primers of ΔbudC-F and ΔbudC-R (Table 2)
and nucleotide sequencing.
Construction of the complementary strain of WX-02
ΔbudC
The complementation of B. licheniformis WX-02 ΔbudC
was conducted with a budC expression plasmid. The B.
licheniformis WX-02 ΔbudC was electrotransformed with
pHYbudC DNA according to the method described previ-
ously [27], and the transformants were first selected by LB
agar plates with 20 μg/mL tetracycline [27], followed with
verification by PCR with primers of P43-budC-TamyL-1
and P43-budC-TamyL-6 (Table 2). The recombinant strain
was designated as WX-02 ΔbudC/pHYbudC.
Detection of BDH and AR activities in cells
The wild strain WX-02, mutant strain WX-02 ΔbudC,
and complementary strain WX-02 ΔbudC/pHYbudC were
cultured for 12, 24 and 36 h. The cell extracts from these
three cultures were prepared for determining the 2,3-BDH
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reaction system contains 4 mmol/L NAD+ and 100 mmol/
L 2,3-butanediol for the BDH assay or 0.2 mmol/L NADH
and 50 mmol/L acetoin for the AR assay [11]. The cell ex-
tracts and reaction system were preheated at 37°C, the
200-μL reaction system was then added to a 96-well UV-
star microplate (Greiner Bio-One, Germany) followed
with addition of 5 μL cell extracts. The microplate was im-
mediately put into a microplate reader (BioTek, USA) and
reacted at 37°C for 5 minutes. Absorbance at 340 nm was
measured initially and the end of the reaction. Under
these conditions, one unit of BDH or AR activity was
defined as 1 μmol of NADH produced or consumed by
1 mg of protein per minute. The protein concentration of
cell extracts was determined by the Coomassie brilliant
blue method [28].Analysis
Cell density was determined by the optical absorbance at
600 nm (OD600). The concentration of residual glucose
was measured by a biosensor equipped with a glucoseox-
idase electrode (SBA-40C, China). Single colonies of the
wild strain of WX-02, mutant strain of WX-02 ΔbudC,
and complementary strain of WX-02 ΔbudC/pHYbudC
on the LB plate were transferred into 250-mL flasks con-
taining 50 mL LB medium and incubated at 37°C for
11 h in an orbital shaker at 180 rpm until the OD600 of
the culture reached approximately 4.2. The cells were
then sub-cultured for 48 h in the same conditions. The
samples were collected periodically to determine the
time course of cell density, residual glucose, and product
(acetoin and 2,3-butanediol) concentrations using previ-
ously described methods [29].
Acetoin, D-2,3-butanediol, and meso-2,3-butanediol were
extracted by ethyl acetate and then quantified using Trace
GC Ultra Gas Chromatograph (Thermo, USA) equipped
with a flame ionization detector and TR-WAX capillary
column (30 m× 0.32 mm ID, 0.25 μm film). Nitrogen was
used as the carrier gas with a flow rate of 1.0 mL/minute;
the injected volume was 1 μL with a splitless injection
mode. The injector temperature and the detector tem-
perature were 215°C and 245°C, respectively. The column
was maintained at 50°C for 1.5 minutes, increased at a rate
of 10°C/minute to 110°C for 0.5 minutes, 5°C/minute to
150°C for 0.5 minutes, and 20°C/minute to 220°C for 1 mi-
nute. The concentration of acetoin and 2,3-butanediol was
quantified using the internal standard (butanol).Abbreviations
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